Home / Flecainide / Canada
CA ATC C01BC04 · updated 2 Nov 2026
Flecainide shortage in Canada
Is there a Flecainide shortage in Canada?
Yes. As of 2 Nov 2026, 2 Flecainide products are reported short in Canada, the first since 31 Oct 2025. The company estimate for the return is 6 Nov 2026 (latest 30 Apr 2027). Main reason: increased demand.
Also short in Italy, Belgium, Japan, Australia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | JAMP FLECAINIDE (100) | JAMP PHARMA CORPORATION | 31 Oct 2025 | 30 Apr 2027 | Increased demand Demand increase for the drug |
| CA | APO-FLECAINIDE (100 BTL) | APOTEX INC | 27 Oct 2026 | 6 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.